NYSE:PMC - PharMerica Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week Range$22.00 - $29.50
VolumeN/A
Average Volume283,015 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
PharMerica Corporation is an institutional pharmacy services company. The Company services healthcare facilities, provides pharmacy management services to hospitals and specialty infusion services to patients outside a hospital setting, and offers the national oncology pharmacy in the United States. Its segments include institutional pharmacy, which provides pharmacy products and services to residents and patients in skilled nursing facilities, nursing centers, assisted living facilities, hospitals and other long-term alternative care settings; specialty infusion services, which provides specialty infusion services focused on providing pharmaceutical products and clinical services to patients in client facilities, hospice and outside of hospital or nursing home settings, and specialty oncology pharmacy, which provides dispensing of oncology drugs, care management and other related services to patients, oncology practices and hospitals.

Receive PMC News and Ratings via Email

Sign-up to receive the latest news and ratings for PMC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryHealth Care Distributors
SectorN/A
CUSIP71714F10
Phone+1-502-6277000

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

PharMerica (NYSE:PMC) Frequently Asked Questions

What is PharMerica's stock symbol?

PharMerica trades on the New York Stock Exchange (NYSE) under the ticker symbol "PMC."

How were PharMerica's earnings last quarter?

PharMerica Co. (NYSE:PMC) announced its earnings results on Thursday, November, 9th. The company reported $0.46 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.49 by $0.03. The company had revenue of $595.10 million for the quarter, compared to analyst estimates of $596.80 million. View PharMerica's Earnings History.

Has PharMerica been receiving favorable news coverage?

Media coverage about PMC stock has trended somewhat positive this week, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. PharMerica earned a news impact score of 1.7 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 2.0 out of 10, indicating that recent news coverage is very unlikely to have an impact on the company's share price in the next several days.

What other stocks do shareholders of PharMerica own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PharMerica investors own include AmerisourceBergen (ABC), Capitol Federal Financial (CFFN), Micron Technology (MU), Tesla (TSLA), Depomed (DEPO), Inovio Pharmaceuticals (INO), Bioblast Pharma (ORPN), Celgene (CELG), Gilead Sciences (GILD) and Horizon Pharma (HZNP).

Who are PharMerica's key executives?

PharMerica's management team includes the folowing people:
  • Geoffrey G. Meyers, Independent Chairman of the Board (Age 72)
  • Gregory S. Weishar, Chief Executive Officer, Director (Age 62)
  • Suresh Vishnubhatla, Executive Vice President - Long-term Care Operations (Age 48)
  • Berard E. Tomassetti, Senior Vice President, Chief Accounting Officer (Age 61)
  • Thomas A. Caneris, Senior Vice President, General Counsel, Secretary (Age 54)
  • Robert A. McKay, Senior Vice President - Purchasing and Trade Relations (Age 55)
  • Frank E. Collins Esq., Independent Director (Age 63)
  • W. Robert Robert Dahl Jr., Independent Director (Age 60)
  • Marjorie W. Dorr, Independent Director (Age 55)
  • Patrick G. LePore, Independent Director (Age 62)

How do I buy shares of PharMerica?

Shares of PMC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is PharMerica's official website?

The official website for PharMerica is http://www.pharmerica.com.

How can I contact PharMerica?

PharMerica's mailing address is 1901 Campus Pl, LOUISVILLE, KY 40299-2308, United States. The company can be reached via phone at +1-502-6277000.


MarketBeat Community Rating for PharMerica (NYSE PMC)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  205 (Vote Outperform)
Underperform Votes:  280 (Vote Underperform)
Total Votes:  485
MarketBeat's community ratings are surveys of what our community members think about PharMerica and other stocks. Vote "Outperform" if you believe PMC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PMC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel